Garry A. Nicholson's most recent trade in Tscan Therapeutics Inc was a trade of 67,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Deferred Restricted Stock Unit (RSU) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 20,000 | 14,389 (0%) | 0% | - | Common Stock | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | 18 Sep 2024 | 14,389 | 0 (0%) | 0% | - | Common Stock | ||
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 10,000 | 34,389 (0%) | 0% | 0 | Common Stock | |
| Tscan Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 23,750 | 23,750 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 24,389 (0%) | 0% | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 33,900 | 33,900 | - | - | Stock Option (Right to buy Common Stock) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 10,000 | 14,389 (0%) | 0% | 0 | Common Stock | |
| Nextcure Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,620 | 19,620 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 4,389 | 4,389 (0%) | 0% | 0 | Common Stock |